RN123 Polyclonal Antibody

The protein encoded by this gene contains a C-terminal RING finger domain, a motif present in a variety of functionally distinct proteins and known to be involved in protein-protein and protein-DNA interactions, and an N-terminal SPRY domain. This protein displays E3 ubiquitin ligase activity toward the cyclin-dependent kinase inhibitor 1B which is also known as p27 or KIP1. Alternative splicing results in multiple transcript variants.

The RN123 Polyclonal Antibody is a highly specialized and meticulously crafted product designed to cater to the needs of researchers and scientists in the field of biotechnology. This antibody is derived from a diverse pool of immunoglobulins, ensuring a broad spectrum of reactivity and enhanced sensitivity in various applications.

With its exceptional specificity and affinity, the RN123 Polyclonal Antibody offers unparalleled performance in immunohistochemistry, immunofluorescence, and Western blotting techniques. Its robust nature allows for reliable and reproducible results, making it an indispensable tool for accurate and precise experimental outcomes.

The RN123 Polyclonal Antibody is meticulously purified and quality-controlled to meet the highest industry standards. Its purity and consistency are guaranteed, ensuring minimal background noise and maximum signal-to-noise ratio. This antibody is manufactured using state-of-the-art techniques and undergoes rigorous testing to ensure its efficacy and reliability.

Furthermore, the RN123 Polyclonal Antibody is provided in a convenient and user-friendly format, allowing for easy handling and storage. Its long shelf life ensures prolonged usability, making it a cost-effective choice for laboratories and research institutions.

In summary, the RN123 Polyclonal Antibody is a cutting-edge product that offers exceptional performance, reliability, and convenience. Its broad reactivity, high specificity, and meticulous purification make it an invaluable asset for researchers seeking accurate and reproducible results in their biotechnological endeavors.